{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005699","form_type":"8-K/A","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2025-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.334022+00:00","generated_at":"2026-05-27T00:27:19.583869+00:00","sec_items":["9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Calidi Biotherapeutics files 8-K/A to add auditor consent to Jan 10 filing","bullets":["Amendment solely adds Exhibit 23.1, consent of Marcum LLP.","No modifications to prior 8-K disclosure; no new financial or operational data.","Filing date Feb 10, 2025; original report filed Jan 10, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005699","json":"https://secwatch.observer/filing/0001493152-25-005699.json","markdown":"https://secwatch.observer/filing/0001493152-25-005699.md","text":"https://secwatch.observer/filing/0001493152-25-005699.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315225005699/0001493152-25-005699-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315225005699/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:27:19.583869+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}